The protein corona that isn't there

Put a nanoparticle in blood and proteins will stick to it. The formed protein corona determines what the particle looks like to the body: where it goes, what takes it up, how long it circulates. One of the sturdiest textbook results in nanomedicine, established on hard particles: polystyrene, gold, silica.

Lipid nanoparticles are not hard particles. They are soft, fluid, membrane-like assemblies. A 2026 study in Nano Letters asked whether the corona picture transfers. Apparently, the answer is no but in a very instructive way.

Plenty of protein but no shell

Cryo-electron microscopy of four LNP formulations with different helper lipids showed none of the discrete peripheral layer that surrounds a plasma-exposed polystyrene bead. What the membranes showed instead was localized thickening and remodeling more suggestive of proteins being recruited into the membrane rather than parked on it.

Proteomics experiments arrived at a similar conclusion from another perspective. Apolipoproteins dominated what came back with the particles. Observed values ranged from roughly 25 to 55% of total intensity depending on the formulation against about 18% in plasma processed in parallel. Such an observation suggests selective enrichment instead of carryover which also seems intuitive - lipoproteins tend to interact with membranes. It says which proteins travel with the particle rather than how they sit on it, since lipoproteins are close enough to LNPs in size and density that co-elution alone cannot settle the structural question.

Molecular dynamics adds a mechanism that is plausible rather than proven: simulated against a cationic bilayer, ApoE4 engages the surface with its N-terminal domain without inserting it, and in some replicates the full-length protein drives its C-terminal tail into the acyl chains. The authors are careful to say that full integration was never reached within the timescales a simulation can cover, so this supports fusion over adsorption without demonstrating it.

An elegant control experiment

In my opinion, the methodological highlight is a two-particle experiment. Both polystyrene nanoparticles and LNPs were exposed to the same purified ApoE4. The experiment was performed in the same vessel and imaged in the same field of view. The polystyrene particle formed a shell. The neighboring LNP did not. Sometimes, a complex finding can be reduced to a straightforward image.

An added benefit: a single image removed an entire class of objections a reviewer could otherwise raise: different experimental conditions, different protein batches, different sample preparation, different imaging parameters. Whatever produced the difference may not be attributed to the handling as the two particles shared all of it. Another piece of evidence: extracellular vesicles, which present a similarly fluid lipid surface, were tested alongside and behaved like the LNPs.

Apart from the intriguing science, I also liked the methodological simplicity. Its lesson generalizes cleanly: when a result depends on which system you are studying, put both systems into the same experiment. A comparison across separate runs argues about the method while a comparison inside one field of view argues about the thing itself.

Two limits belong on the record before anyone reaches for the consequences. The findings rest on a single ionizable lipid, so whether they carry to the two-tailed lipids in clinical use needs its own study. And cryo-TEM cannot resolve how deep the insertion goes, which leaves blebbing as a co-occurring explanation for some of the dense structures rather than a ruled-out one.

My takeaway: the practical consequence holds potential to reframe formulation design. If plasma proteins fuse rather than adsorb, PEGylation cannot do the whole job on its own, because shielding surface area does not address fusogenic capacity. In such a scenario, the interaction becomes something to steer instead of suppress. Favoring fusion with a particular lipoprotein class constitutes a potential route to organ tropism: ApoE engagement is the well-known path to hepatocyte uptake. Which means the corona (do we need a new name?) moves from nuisance to design parameter.